Cargando…
Collateral Glucose-Utlizing Pathwaya in Diabetic Polyneuropathy
Diabetic polyneuropathy (DPN) is the most common neuropathy manifested in diabetes. Symptoms include allodynia, pain, paralysis, and ulcer formation. There is currently no established radical treatment, although new mechanisms of DPN are being vigorously explored. A pathophysiological feature of DPN...
Autores principales: | Mizukami, Hiroki, Osonoi, Sho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7796340/ https://www.ncbi.nlm.nih.gov/pubmed/33374137 http://dx.doi.org/10.3390/ijms22010094 |
Ejemplares similares
-
RAGE activation in macrophages and development of experimental diabetic polyneuropathy
por: Osonoi, Sho, et al.
Publicado: (2022) -
Serine supplementation: Is it a new option for the treatment of diabetic polyneuropathy?
por: Mizukami, Hiroki
Publicado: (2023) -
Exploring a New Therapy for Diabetic Polyneuropathy – The Application of Stem Cell Transplantation
por: Mizukami, Hiroki, et al.
Publicado: (2014) -
Update on the management of diabetic polyneuropathies
por: Shakher, Jayadave, et al.
Publicado: (2011) -
Role of glucosamine in development of diabetic neuropathy independent of the aldose reductase pathway
por: Mizukami, Hiroki, et al.
Publicado: (2020)